11870Elecsys Anti-HCV II
Albania medical device registration · Roche Diagnostics GmbH, Sandhofer Strasse 116, D-68305 Mannheim · Invitro · Model Elecsys Anti-HCV II: 08836981190; 08837031190; 08837058190 · Registered April 28, 2022
- Risk Class
- Invitro
- Product Model
- Elecsys Anti-HCV II: 08836981190; 08837031190; 08837058190
- Product Name
- Elecsys Anti-HCV II
- Registration Date
- April 28, 2022
- Analysis ID
- 11870
Reagent per matjen e hepatitit C ne plazmen humane
Access comprehensive regulatory information for Elecsys Anti-HCV II in the Albania medical device market through Pure Global AI's free database. This Invitro medical device is manufactured by Roche Diagnostics GmbH, Sandhofer Strasse 116, D-68305 Mannheim. The device was registered on April 28, 2022.
This page provides complete registration details including product model (Elecsys Anti-HCV II: 08836981190; 08837031190; 08837058190), manufacturer information, risk classification, and regulatory compliance data from the official Albania medical device database. Pure Global AI offers free access to Albania's medical device registry, helping global MedTech companies navigate Albania regulations efficiently.